Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer.
Looking at options history for Pfizer PFE we detected 18 trades.
If we consider the specifics of each trade, it is accurate to state that 44% of the investors opened trades with bullish expectations and 55% with bearish.
From the overall spotted trades, 7 are puts, for a total amount of $342,961 and 11, calls, for a total amount of $463,767.
Predicted Price Range
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $15.0 to $35.0 for Pfizer over the last 3 months.
Volume & Open Interest Development
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Pfizer's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Pfizer's substantial trades, within a strike price spectrum from $15.0 to $35.0 over the preceding 30 days.
Pfizer Option Activity Analysis: Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PFE | PUT | SWEEP | BULLISH | 06/20/25 | $3.9 | $3.8 | $3.8 | $30.00 | $113.6K | 3.1K | 349 |
| PFE | CALL | SWEEP | BEARISH | 01/16/26 | $2.92 | $2.91 | $2.91 | $30.00 | $92.4K | 31.7K | 819 |
| PFE | PUT | SWEEP | BULLISH | 06/14/24 | $0.76 | $0.71 | $0.71 | $28.50 | $55.4K | 11.8K | 1.0K |
| PFE | CALL | TRADE | BEARISH | 01/16/26 | $2.94 | $2.91 | $2.91 | $30.00 | $54.4K | 31.7K | 1.0K |
| PFE | PUT | SWEEP | BULLISH | 07/19/24 | $0.77 | $0.76 | $0.76 | $28.00 | $53.8K | 12.4K | 1.1K |
About Pfizer
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Having examined the options trading patterns of Pfizer, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Where Is Pfizer Standing Right Now?
- With a volume of 17,018,916, the price of PFE is down -0.94% at $28.31.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 50 days.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Pfizer, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
